X4 Pharmaceuticals Executive Chairman Adam R. Craig reports acquisition of $11,883.64 in common shares

XFOR•2026-10-19

Executive Chairman Adam R. Craig purchased 4,600 X4 Pharmaceuticals common shares at $2.5834 each, increasing his direct beneficial ownership to 333,251 shares.

1. Share purchase

Craig purchased 4,600 common shares at $2.5834 each, for a total of $11,883.64. His direct beneficial ownership rose to 333,251 shares.

Sources

X4 Pharmaceuticals Executive Chairman Adam R. Craig reports acquisition of $11,883.64 in common shares

Sec

X4 Pharmaceuticals Executive Chairman Adam R. Craig reports acquisition of $11,883.64 in common shares

1. Share purchase

Related News

EverQuote Chief Accounting Officer Jon Ayotte sells common shares worth $9,570.20

IDT EVP of strategic and legal affairs Menachem Ash sells $410,000 in common shares

Union Pacific defends Norfolk Southern deal benefits with detailed regulatory evidence

Sources

X4 Pharmaceuticals Executive Chairman Adam R. Craig reports acquisition of $11,883.64 in common shares

FNB Q3 net interest income rises on growth in earning assets and lower deposit costs

Soluna Holdings holds annual shareholder meeting